MTOR and neoplasm: Further analysis at the protein level demonstrated a positive correlation between phospho-mTOR (S2448), a key downstream effector of PI3K-Akt signaling and a biomarker indicating the activation of mTOR signaling, and THY1 (encoding CD90) gene expression across TCGA MPM tumor samples (Figure 4F).